Randomized trial showing efficacy and safety of twice‐daily remogliflozin etabonate for the treatment of type 2 diabetes
暂无分享,去创建一个
W. Wilkison | R. Dobbins | A. Sykes | S. Walker | L. Kler | D. Dorey | R. O’Connor-Semmes | J. D. Lorimer | D. J. Dorey | J. D. Lorimer | W. O. Wilkison | D. Dorey